Effect of Transcutaneous Electrical Nerve Stimulation on PODD in Bariatric Surgery Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorCairo University

About this trial

Researchers aim to evaluate impact of transcutaneous electric nerve stimulator on the incidence of postoperative diaphragmatic dysfunction in patients living with obesity undergoing bariatric surgery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Body mass index > 40 kg/m2

ASA II

Disqualifiers

Limited diaphragmatic ultrasound views

Patient with pulmonary diseases (COPD, bronchial asthma, and interstitial fibrosis)

Patient refusal

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous nerve stimulator

    Device

    The EM49 will be set to a TENS program with a frequency of 80-100 Hz and a pulse width of 200 μs

  • Sham TENS

    Device

    Electrodes will be placed identically, but no current will be delivered (sham TENS)

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: TENSActive comparator 1 intervention
Group B: ControlSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of postoperative diaphragmatic dysfunction

Diaphragmatic excursion \< 10 mm 2 hours after surgery

Time frame
2 hours after surgery

Secondary outcomes

1

Forced vital capacity (liters)

is the maximum volume of air that can forcibly exhaled after taking maximum breath

Time frame
Before and at 2 and 24 hours postoperatively
2

Numeric rating scale

To quantify pain from 0 to 10 (with 10 indicates worst pain)

Time frame
Within 24 hours after surgery
3

Nalbuphine consumption

Total postoperative nalbuphine consumption

Time frame
24 hours after surgery
4

Forced expiratory volume in one second (Liter)

Maximum volume of air can be exhaled in the first second after maximum inspiration

Time frame
Before and at 2 and 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.